Germany tells some patients to stop using Celebrex
Key points
- Germany's drug regulator on Monday told patients with cardiovascular risks to stop using Pfizer's arthritis drug Celebrex after new data emerged linking it to an elevated risk of heart attacks.
- The drug regulator said in a statement it was not "justifiable" to treat patients with a history of heart attack and stroke with Celebrex.
- The regulator urged the use of alternative drugs, or a reduction in dose if a patient cannot be treated without Celebrex.
- Pfizer last week said Celebrex more than doubled the risk of heart attack in a large cancer-prevention trial, a setback that comes just weeks after Merck & Co. recalled its similar Vioxx drug due to heart safety risks.
Germany's drug regulator on Monday told patients with cardiovascular risks to stop using Pfizer's arthritis drug Celebrex after new data emerged linking it to an elevated risk of heart attacks.
The drug regulator said in a statement it was not "justifiable" to treat patients with a history of heart attack and stroke with Celebrex.
The regulator urged the use of alternative drugs, or a reduction in dose if a patient cannot be treated without Celebrex.
Pfizer last week said Celebrex more than doubled the risk of heart attack in a large cancer-prevention trial, a setback that comes just weeks after Merck & Co. recalled its similar Vioxx drug due to heart safety risks.
Pfizer said doctors should be made aware of the health risks in prescribing Celebrex to their patients, but the company does not plan to recall its popular arthritis drug.
Celebrex is one of Pfizer's biggest products, with 2003 sales of $1.9 billion.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsWhen Doctors Tell Patients to Quit Smoking, They Listen
Doctors who take a few minutes to talk with patients about their smoking — maybe passing along a leaflet or a sample of nicotine gum — make a difference when it comes to helping them quit successfully, according to a…
30 April 2008
NewsCelebrex risky in high-risk patients, study finds
Doctors should prescribe the lowest doses of Celebrex possible in patients at high risk of heart problems, researchers who did a combined analysis of six studies of the Pfizer Inc pain drug said on Monday. The analysis…
1 April 2008
NewsHow can I stop smoking? The Cochrane Library has evidence that can help
Acupuncture? Nicotine patches? Telephone therapy? Antidepressants? Cognitive behavioural therapy? Which work? Which have no effect? Which are dangerous? Confused? Over 40 Cochrane reviews analyse the evidence. For…
27 June 2007
